A randomized, double blind, parallel-group, placebo controlled study to evaluate the efficacy and safety of IBP-9414 in premature infants 500-1500 grams birth weight in the prevention of necrotizing enterocolitis ¿ The Connection study

Administered By

Awarded By

Contributors

Start/End

  • August 23, 2019 - August 31, 2021